Madrigal Pharmaceuticals
MDGL
#2088
Rank
$8.80 B
Marketcap
$379.10
Share price
-4.45%
Change (1 day)
-30.82%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): -$5.91

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$5.91. In 2025 the company made an earnings per share (EPS) of -$10.69 an increase over its 2024 EPS that were of -$22.11.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$5.91-44.71%
2025-$10.69-51.65%
2024-$22.11
2022-$17.2317.93%
2021-$14.6111.61%
2020-$13.09140.18%
2019-$5.45146.61%
2018-$2.21-12.99%
2017-$2.54-91.03%
2016-$28.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-$0.19-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$0.95-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA